Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review

Published:2018 Issue:4 Volume:57 Page:527-535
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ohara Nobumasa¹,Ohashi Kazumasa²,Fujisaki Toshiya²,Oda Chiyumi¹,Ikeda Yohei³,Yoneoka Yuichiro⁴,Hashimoto Takehisa⁵,Hasegawa Go⁶,Suzuki Kazuo²,Takada Toshinori²

Affiliation:

1. Department of Endocrinology and Metabolism, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

2. Department of Respiratory Medicine, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

3. Department of Radiology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

4. Department of Neurosurgery, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

5. Department of Thoracic Surgery, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

6. Department of Pathology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/4/57_9074-17/_pdf

Reference34 articles.

1. 1. Andrioli M, Pecori Giraldi F, Cavagnini F. Isolated corticotrophin deficiency. Pituitary 9: 289-295, 2006.

2. 2. Pennock GK, Chow LQ. The evolving role of immune checkpoint inhibitors in cancer treatment. Oncologist 20: 812-822, 2015.

3. 3. Michot JM, Bigenwald C, Champiat S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54: 139-148, 2016.

4. 4. Torino F, Corsello SM, Salvatori R. Endocrinological side-effects of immune checkpoint inhibitors. Curr Opin Oncol 28: 278-287, 2016.

5. 5. Falorni A, Minarelli V, Bartoloni E, Alunno A, Gerli R. Diagnosis and classification of autoimmune hypophysitis. Autoimmun Rev 13: 412-416, 2014.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated Adrenocorticotropic Hormone Deficiency Diagnosed After the Cessation of Glucocorticoid Therapy for Eosinophilic Esophagitis: A Case Report;Cureus;2024-08-05

2. PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports;Drug Discoveries & Therapeutics;2024-02-29

3. Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literature review;Frontiers in Immunology;2024-01-16

4. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report;Medicine;2023-12-22

5. Hypopituitarism induced by pembrolizumab plus axitinib in the treatment of metastatic renal cell carcinoma: A case report;Oncology Letters;2023-12-20